CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Feb. 28, 2014	Feb. 28, 2013
Cash flows from operating activities
Net loss	$ (317,440)	$ (385,845)
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation	42,012	99,868
Change in fair value of derivative liability	7,259	47,900
Changes in assets and liabilities
Other current assets	7,326	(514)
Accounts payable and accrued liabilities	65,707	(58,525)
Deferred revenue	(12,329)	(12,329)
Net cash used in operating activities	(207,465)	(309,445)
Cash flows from investing activities	0	0
Cash flows from financing activities
Proceeds from the exercise of stock warrants	225,630	164,590
Change in advance from warrant holder	76,595	235,410
Net cash provided by financing activities	302,225	400,000
Net increase in cash and cash equivalents	94,760	90,555
Cash and cash equivalents at beginning of period	146,205	199,472
Cash and cash equivalents at end of period	240,965	290,027
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	730	698
Noncash Investing and Financing Activities:
Issuance of common stock for conversion of 4.75% debentures	$ 2,070	$ 1,510